WebSep 20, 2024 · Dilute the Cerezyme solution promptly with 0.9% Sodium Chloride Injection, USP, to a final volume of 100 to 200 mL. For patients weighing less than 18 kg, dilute Cerezyme to a final volume of 100 mL. Gently invert infusion bag to mix the solution, avoiding vigorous shaking and agitation. Websupport storage of Cerezyme and other infusion supplies. • In case the patient carries out the procedure him/herself o The patient/caregiver will strictly follow the prescribed method of administration of Cerezyme as stated in the Patient Manual and Reconstitution guide. o The patient/caregiver records each administration of Cerezyme in the ...
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
WebCerezyme ® (imiglucerase) for injection is indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia (low red blood cell count) thrombocytopenia (low blood … Understanding Gaucher disease. Gaucher (pronounced go-shay) disease is a rare, … Considering Cerezyme - Cerezyme® (imiglucerase) Enzyme replacement … Infusion into the bloodstream bypasses your body’s digestive processes. Your … Support and Resources - Cerezyme® (imiglucerase) Enzyme replacement … Get Access - Cerezyme® (imiglucerase) Enzyme replacement therapy Cerezyme ® (imiglucerase for ... Pre-treatment with antihistamines and/or … This study evaluated the efficacy and safety of Cerezyme in certain bone parameters … Safety - Cerezyme® (imiglucerase) Enzyme replacement therapy Treatment Options - Cerezyme® (imiglucerase) Enzyme replacement … How Is Gaucher Disease Inherited - Cerezyme® (imiglucerase) Enzyme … WebFollowing infusion, plasma enzymatic activity declined rapidly with a half-life ranging from 3.6 to 10.4 minutes. Plasma clearance ranged from 9.8 to 20.3 mL/min/kg (mean ± S.D., 14.5 ± 4.0 ... Cerezyme® (imiglucerase for injection) is administered by intravenous infusion over 1–2 hours. Cerezyme® Cerezyme ... canine spectra 10 side effects
Cerezyme European Medicines Agency
WebCerezyme is administered through intravenous infusion. The dosage and frequency will depend on the patient’s weight and the severity of Gaucher disease. The most common schedule takes place bi-weekly and is usually about 60 units per kg of body weight. Please refer to the full prescribing information. WebCerezyme is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia, thrombocytopenia, bone disease, hepatomegaly or splenomegaly. Webimiglucerase Home Infusion Patient Manual MAY 2015 CERZ-UK-10/10-2254A (1) 5 Organisation Patient x You and/or your caregiver must agree to receive the treatment at home. x The home environment should be conducive to the provision of the home infusion therapy including a clean environment with electricity, water, telephone access, … five bx